The effect of hemodialysis and dialyzer biocompatibility on erythrocyte glutathione-defense system in chronic hemodialysis patients

International Journal of Artificial Organs

Volumn 28, Issue 6, 2005, Pages 576-582

  Alhamdani, Mohamed Saiel Saeed ^a   Al Najjar, A F ^a   Al Kassir, A H ^a  

^a MUSTANSIRIYAH UNIVERSITY   (Iraq)

Author keywords

Biocompatibility; Cuprophane; Erythrocyte; Glutathione; Polysulfone

Indexed keywords

BIOCOMPATIBILITY; BLOOD; ENZYMES; FREE RADICALS; HEMODIALYZERS; NETWORK SECURITY; PATIENT TREATMENT; PEPTIDES;

CUPROPHANE; DEFENCE SYSTEMS; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; GLUTATHIONE S-TRANSFERASES; GLUTHATHIONE; HAEMODIALYSIS; HEMODIALYSIS PATIENT; POLYSULPHONE; REACTIVE OXYGEN SPECIES; UREMIC PATIENTS;

DIALYSIS;

ANTIOXIDANT; CUPROPHANE; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; POLYSULFONE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DIALYSIS MEMBRANE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; LONG TERM CARE; MALE; OXIDATIVE STRESS; UREMIA;

EID: 23144465496     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800606     Document Type: Article

References (40)

1. Galli F, Canestrari F, Bellomo G. Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol 1999; 127: 1-31.
2. Durak I, Akiol O, Basesme E, Cambolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
3. Ceballos-Picot J, Witko-Sarsat V, Merad-Boudia M, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996; 21: 845-953.
4. Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant 1991; 6 (suppl 3): S66-70.
5. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane. Int J Artif Organs 2002; 25: 529-37.
6. Kubala L, Ciz M, Soska V, Cerny J, Lojek A. Influence of polysulfone and hemophan hemodialysis membranes on phagocytes. Gen Physiol Biophys 2002; 21: 367-80.
7. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant 1994; 9: 389-94.
8. Richie JP Jr, Skowronski L, Abraham P, Leutzinger Y. Blood glutathione oncentrations in a large-scale human study. Clin Chem 1996; 42: 64-70.
9. Kachmar JF, Moss DW. Glucose-6-phosphate dehydrogenase. In: Tietz NW, ed. Foundamentals of Clinical Chemistry. Philadelphia: WB Saunders; 1982. pp. 666-70.
10. Lee KT, Tan IK, Seet AM. A new method for determination of NAD(P)H-dependent glutathione reductase in erythrocyte and plasma. Clin Chem Acta 1970; 58: 101.
11. Paglia DE, Valantine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 30: 158-69.
12. Galli F, Rovidati S, Benedetti S, Buoncristiani U, Covarelli C, Floridi A, Canestrari F. Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis. Clin Chem 1999; 45: 1781-8.
13. Durak I, Akiol O, Basesme E, Cambolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
14. Alhamdani MS. Impairment of glutathione biosynthetic pathway in uremia and dialysis. Nephrol Dial Transplant 2005; 20: 124-8.
15. Lins RL, Zachee P, Daelemans R, Vanden Broecke E, Boogaerts MA, De Broe ME. Red blood cell function and beta 2 microglobulin kinetics during cuprophane hemodialysis: A hypothesis. Int J Artif Organs 1989; 12: 638-41.
16. Petersen J, Moore RM Jr, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. Am J Kidney Dis 1991; 17: 174-8.
17. Milman N. Erythrocyte glucose-6-phosphate dehydrogenase in chronic renal failure and after renal transplantation. Scand J Hematol 1980; 24: 307-14.
18. Shainkin R, Giatt Y, Berlyne GM. The toxicity of guanidine compounds in the red blood cells in uremia and the effect of hemodialysis. Nephron 1982; 31: 20-23.
19. Niwa T, Tsukushi S. 3-deoxyglucosone and AGEs in uremic complications: Inactivation of glutathione peroxidase by 3-deoxyglucosone. Kidney Int 2001; 78 (suppl): S37-41.
20. Kiho T, Asahi T, Usi S, Matsunaga T, Ukai S. Effect of 3-deoxyglucosone on the activities of enzymes responsible for glucose metabolism in mouse liver. Biol Pharma Bull 1996; 19: 1106-8.
21. Slominska EM, Szolkiewicz M, Smolenski FIT, Rutkowski B, Swierczynski J. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP. Nephron 2002; 91: 286-91.
22. Ben-Bassat I, Beutler E. inhibition by ATP of erythrocyte glucose-6-phosphate dehydrogenase variants. Proc Soc Exp Biol Med 1973; 142: 410-1.
23. Rodriguez-Segade S, Ramos-Martinez JI, Freire M. Reversal effect of oxidized glutathione on the inhibition of G6PD by NADPH. Biochem J 1985; 231: 805-6.
24. Melissinos KG, Delidou AZ, Varsou AG, Begietti SS, Drivas GJ. Serum and erythrocyte glutathione reductase activity in chronic renal failure. Nephron 1981; 28: 76-9.
25. Martin-Mateo MC, Sanchez-Portugal M, Iglesias S, de Paula A, Bustamante J. Oxidative stress in chronic renal failure. Ren Fail 1999; 21: 155-67.
26. Brunetti P, Parma A, Nenci GG. Studies on renal anemias. I. Increase of erythrocyte glutathion-reductase in uremic states. Haematologica. 1965; 50: 415-46.
27. Ito T, Niwa T, Matsui E, Oishi N, Yagi K. Plasma flavin levels of patients receiving long-term hemodialysis. Clin Chim Acta 1972; 39: 125-9.
28. Kopczynski Z, Chmiel J, Czarnecki R. Investigations on riboflavin penetration across erythrocyte cell membrane in healthy subjects and patients with chronic renal failure. Acta Physiol Pol 1980; 31: 209-15.
29. Nohara Y, Suzuki J, Kinoshita T, Watanabe M. Creatinine inhibits D-amino acid oxidase. Nephron 2002; 91: 281-5.
30. Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS. Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron 1999; 81: 278-83.
31. Giray B, Kan E, Bali M, Hincal F, Basaran N. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clin Chim Acta 2003; 338: 91-8.
32. Schettler V, Wieland E, Methe H, Schuff-Werner P, Muller G. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant 1998; 13: 2588-93.
33. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-5.
34. Hirayama A, Nagase S, Gotoh M, Takemura K, Tomida C, Ueda A, Aoyagi K, Terao J, Koyama A. Hemodialysis does not influence peroxidative state already present in uremia. Nephron 2000; 86: 436-40.
35. Pigeolet E, Corbisier P, Houbion A, Lambert DMichiels C, Raes M, Zachary M, Remacle J. Glutathione peroxidase, superoxides dismutase, and catalase inactivation by peroxide and oxygen derived free radicals. Mech Age Dev 1990; 51: 238-97.
36. Schindler R. Elimination of cytokines from plasma by ultrafiltration using conventional polysulfone or DIAPES membranes. Contrib Nephrol 2003; 138: 37-42.
37. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
38. Alin P, Danielson UH, Mannervik B. 4-hydroxyalk-2-enals are substrates for glutathione S-transferase. FEBS Lett 1985; 179: 267-70.
39. Canestrari F, Buoncristiani U, Galli F, Giorgini A, Albertini MC, Carobi C, Pascucci M, Bossu M. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995; 234: 127-36.
40. Vlassara H. Serum advanced glycosylation end products: A new class of uremic toxins. Blood Purif 1994; 12: 54-9.